CD8A and hepatocellular carcinoma: In HCC cells that are resistant to oxaliplatin, a combination of anti-CCL20 and anti-PD-L1 reduced the infiltration of MDSCs while increasing the accumulation of CD8 + T cells, thereby inhibiting HCC progression [76].